EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Building a biotechnology company? Check this Indication Checklist

William N Hait

Trends in Biotechnology · 2026-08

DOI: 10.1016/j.tibtech.2026.07.033 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Trends in Biotechnology, 2026-08. Verfasst von William N Hait. Beteiligte Einrichtung: Bill Hait Biomedical Innovations LLC, 13471 Le Havre Dr, Palm Beach Gardens, FL 33410, USA. Electronic address: Williamhait49@gmail.com. Die Arbeit nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Biotechnology companies must carefully consider the choice of the first disease indication for their new drug. There are several key elements that can help guide this critical decision. Drawing on years of experience, this article provides an 'Indication Checklist' with recommendations designed to help.

Schlagwörter

Stichwörter der Autor:innen

biotechnologychecklistfirst indication

Autor:innen und Institutionen

  • Bill Hait Biomedical Innovations LLC, 13471 Le Havre Dr, Palm Beach Gardens, FL 33410, USA. Electronic address: Williamhait49@gmail.com.

Zitieren

APA

Hait, W. N. (2026). Building a biotechnology company? Check this Indication Checklist. Trends in Biotechnology. https://doi.org/10.1016/j.tibtech.2026.07.033

Vancouver

Hait WN. Building a biotechnology company? Check this Indication Checklist. Trends in Biotechnology. 2026. doi:10.1016/j.tibtech.2026.07.033

BibTeX
@article{Hait2026,
  author = {Hait, William N},
  title = {Building a biotechnology company? Check this Indication Checklist},
  journal = {Trends in Biotechnology},
  year = {2026},
  doi = {10.1016/j.tibtech.2026.07.033}
}
Kostenlos starten →